| 000 | 01487 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250513163025.0 | ||
| 264 | 0 | _c19990217 | |
| 008 | 199902s 0 0 eng d | ||
| 022 | _a0098-1532 | ||
| 024 | 7 |
_a10.1002/(sici)1096-911x(199902)32:2<106::aid-mpo7>3.0.co;2-j _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTeinturier, C | |
| 245 | 0 | 0 |
_aClinical and prognostic aspects of adrenocortical neoplasms in childhood. _h[electronic resource] |
| 260 |
_bMedical and pediatric oncology _cFeb 1999 |
||
| 300 |
_a106-11 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 |
_aAdrenal Cortex Neoplasms _xdiagnosis |
| 650 | 0 | 4 |
_aAntineoplastic Agents, Hormonal _xtherapeutic use |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfant |
| 650 | 0 | 4 |
_aKidney Neoplasms _xdiagnosis |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMitotane _xadministration & dosage |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aSurvival Rate |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aPauchard, M S | |
| 700 | 1 | _aBrugières, L | |
| 700 | 1 | _aLandais, P | |
| 700 | 1 | _aChaussain, J L | |
| 700 | 1 | _aBougnères, P F | |
| 773 | 0 |
_tMedical and pediatric oncology _gvol. 32 _gno. 2 _gp. 106-11 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/(sici)1096-911x(199902)32:2<106::aid-mpo7>3.0.co;2-j _zAvailable from publisher's website |
| 999 |
_c9911773 _d9911773 |
||